期刊
NATURE COMMUNICATIONS
卷 7, 期 -, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/ncomms12451
关键词
-
资金
- Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development (AMED) [16ck0106096h0003]
- Japan Society for the Promotion of Science (JSPS) KAKENHI grant [15H05911, 15H05670, 15K14429, 22590516, 19390359]
- Princess Takamatsu Cancer Research Fund
- National Cancer Center Research and Development Fund [26-A-8, 26-A-1]
- Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)
- AMED
- MEXT
- Grants-in-Aid for Scientific Research [19390359, 15H05911, 15K10275, 15H05908, 22590516, 16H06277] Funding Source: KAKEN
Lung adenocarcinoma driven by somatic EGFR mutations is more prevalent in East Asians (30-50%) than in European/Americans (10-20%). Here we investigate genetic factors underlying the risk of this disease by conducting a genome-wide association study, followed by two validation studies, in 3,173 Japanese patients with EGFR mutation-positive lung adenocarcinoma and 15,158 controls. Four loci, 5p15.33 (TERT), 6p21.3 (BTNL2), 3q28 (TP63) and 17q24.2 (BPTF), previously shown to be strongly associated with overall lung adenocarcinoma risk in East Asians, were re-discovered as loci associated with a higher susceptibility to EGFR mutation-positive lung adenocarcinoma. In addition, two additional loci, HLA class II at 6p21.32 (rs2179920; P = 5.1 x 10(-17), per-allele OR = 1.36) and 6p21.1 (FOXP4) (rs2495239; P = 3.9 x 10(-9), per-allele OR = 1.19) were newly identified as loci associated with EGFR mutation-positive lung adenocarcinoma. This study indicates that multiple genetic factors underlie the risk of lung adenocarcinomas with EGFR mutations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据